Researchers have found that elevated cerebrospinal fluid levels of phosphorylated tau231, a damaged tau protein found in patients with Alzheimer’s disease, may be an early diagnostic biomarker for Alzheimer’s disease in healthy adults.
Researchers have found that elevated cerebrospinal fluid levels of phosphorylated tau231, a damaged tau protein found in patients with Alzheimer’s disease, may be an early diagnostic biomarker for Alzheimer’s disease in healthy adults.